AXA S.A. - CHINA BIOLOGIC PRODS INC ownership

CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 137 filers reported holding CHINA BIOLOGIC PRODS INC in Q1 2017. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.

Quarter-by-quarter ownership
AXA S.A. ownership history of CHINA BIOLOGIC PRODS INC
ValueSharesWeighting
Q2 2017$10,669,000
+32.7%
94,334
+17.5%
0.05%
+33.3%
Q1 2017$8,037,000
-2.7%
80,266
+4.5%
0.04%
-7.7%
Q4 2016$8,257,000
+10.4%
76,794
+27.8%
0.04%
+18.2%
Q3 2016$7,480,00060,0880.03%
Other shareholders
CHINA BIOLOGIC PRODS INC shareholders Q1 2017
NameSharesValueWeighting ↓
WARBURG PINCUS LLC 8,344,200$960,918,0007.67%
RUDMAN ERROL M 130,201$14,994,0005.06%
Ativo Capital Management LLC 59,101$7,258,0002.56%
Kylin Management 188,226$21,676,0002.36%
Monashee Investment Management LLC 40,000$4,606,0002.17%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 62,866$7,240,0001.91%
Cormorant Asset Management, LP 111,500$12,840,0001.71%
OBERWEIS ASSET MANAGEMENT INC/ 53,500$6,161,0001.63%
Perceptive Advisors 147,604$16,998,0001.02%
Granite Point Capital Management, L.P. 29,160$3,358,0000.98%
View complete list of CHINA BIOLOGIC PRODS INC shareholders